Background: The combination dextropropoxyphene/paracetamol (DXP/P) was the most prescribed opioid analgesic until its withdrawal in 2011.
Objectives: This study investigated dispensations of analgesics in chronic users of DXP/P during the 18 months following its withdrawal.
Methods: A cross-sectional study repeated yearly was conducted by using the French reimbursement database from 2006 to 2015.